Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Bolt Biotherapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- −6 vs. Q2 2022
- Shares held
- 26.8M
- −39.0K (−0.1%) vs. Q2 2022
- Total value
- $39.7M
- −$15.1M (−27.6%) vs. Q2 2022
- New holders
- 7
- 11 more added
- Sold out
- 13
- 22 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 3,871,291 | $5.73M | 0.63% | 00.0% | Unchanged |
| Novo Holdings A/S | 3,703,991 | $5.48M | 0.26% | −800,000−17.8% | Reduced |
| Sofinnova Investments, Inc. | 2,754,437 | $4.08M | 0.26% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,752,048 | $4.07M | 0.01% | −3,278−0.1% | Reduced |
| Suvretta Capital Management, LLC | 2,672,000 | $3.96M | 0.17% | +441,750+19.8% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.80M | 1.02% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.73M | 1.10% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,049,153 | $1.55M | 0.36% | 00.0% | Unchanged |
| Vanguard Group Inc | 940,269 | $1.39M | 0.00% | +50,477+5.7% | Added |
| OrbiMed Advisors LLC | 771,059 | $1.14M | 0.02% | +771,059 | New |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $1.06M | 0.07% | 00.0% | Unchanged |
| Newtyn Management, LLC | 600,000 | $888.0K | 0.19% | −148,252−19.8% | Reduced |
| Ra Capital Management, L.P. | 533,432 | $789.0K | 0.02% | +83,291+18.5% | Added |
| BlackRock Inc. | 443,196 | $657.0K | 0.00% | −7,135−1.6% | Reduced |
| Hawkeye Capital Management, LLC | 415,039 | $614.0K | 0.40% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 393,858 | $583.0K | 0.00% | −144,715−26.9% | Reduced |
| Assenagon Asset Management S.A. | 279,981 | $414.0K | 0.00% | +4,429+1.6% | Added |
| Oasis Management Co Ltd. | 280,000 | $414.0K | 0.07% | +172,500+160.5% | Added |
| Tang Capital Management LLC | 200,000 | $296.0K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 142,223 | $210.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 118,379 | $175.0K | 0.00% | −73,477−38.3% | Reduced |
| Caas Capital Management LP | 116,777 | $173.0K | 0.02% | +116,777 | New |
| Privium Fund Management (UK) Ltd | 116,516 | $172.0K | 0.22% | +116,516 | New |
| Bridgeway Capital Management, LLC | 113,200 | $168.0K | 0.00% | +47,700+72.8% | Added |
| Ergoteles LLC | 88,174 | $130.0K | 0.00% | −17,481−16.5% | Reduced |
| FMR LLC | 79,265 | $117.0K | 0.00% | −497−0.6% | Reduced |
| Morgan Stanley | 71,044 | $105.0K | 0.00% | −339,827−82.7% | Reduced |
| Russell Investments Group, Ltd. | 64,995 | $96.0K | 0.00% | −31,105−32.4% | Reduced |
| Marquette Asset Management, LLC | 63,779 | $94.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 48,737 | $72.0K | 0.00% | 00.0% | Unchanged |
| Bailard, Inc. | 46,383 | $69.0K | 0.00% | +46,383 | New |
| Gsa Capital Partners LLP | 35,561 | $53.0K | 0.01% | −17,130−32.5% | Reduced |
| Northern Trust Corp | 32,279 | $48.0K | 0.00% | +10,907+51.0% | Added |
| Eversept Partners, LP | 31,172 | $46.1K | 0.01% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 25,380 | $38.0K | 0.00% | −5,436−17.6% | Reduced |
| Schonfeld Strategic Advisors LLC | 19,200 | $29.0K | 0.00% | −3,900−16.9% | Reduced |
| Qube Research & Technologies Ltd | 19,286 | $29.0K | 0.00% | −1,187−5.8% | Reduced |
| Tower Research Capital LLC (TRC) | 18,537 | $28.0K | 0.00% | +10,492+130.4% | Added |
| Man Group plc | 17,899 | $26.0K | 0.00% | – | – |
| Prudential Financial Inc | 16,200 | $24.0K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 14,065 | $21.0K | 0.00% | +246+1.8% | Added |
| Bank of New York Mellon Corp | 12,685 | $19.0K | 0.00% | −170−1.3% | Reduced |
| Goldman Sachs Group Inc | 12,145 | $18.0K | 0.00% | −21,616−64.0% | Reduced |
| Cubist Systematic Strategies, LLC | 10,228 | $15.0K | 0.00% | −4,384−30.0% | Reduced |
| Dimensional Fund Advisors LP | 10,071 | $15.0K | 0.00% | +10,071 | New |
| JPMorgan Chase & Co | 2,364 | $3.00K | 0.00% | +915+63.1% | Added |
| Federated Hermes, Inc. | 2,143 | $3.00K | 0.00% | +2,143 | New |
| Bank of America Corp | 798 | $1.00K | 0.00% | −5,228−86.8% | Reduced |
| Citigroup Inc | 493 | $1.00K | 0.00% | −365−42.5% | Reduced |
| Northwestern Mutual Wealth Management Co | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 481 | $1.00K | 0.00% | −49−9.2% | Reduced |
| China Universal Asset Management Co., Ltd. | 353 | $1.00K | 0.00% | +353 | New |
| Ellevest, Inc. | 32 | $0 | 0.00% | −1,167−97.3% | Reduced |
| Wells Fargo & Company | 145 | $0 | 0.00% | +62+74.7% | Added |
| Barclays PLC | 139 | $0 | 0.00% | −120−46.3% | Reduced |
| Salem Investment Counselors Inc | 40 | $0 | 0.00% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −36,426−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −34,754−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −34,751−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −26,300−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,535−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,994−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,511−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,833−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −188−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |